Law360, New York (January 1, 2018, 3:04 PM EST) -- Multidistrict litigation emerging from a deluge of lawsuits filed against pharmaceutical companies in the midst of the opioid epidemic will seize attorneys’ attention as cases take shape in the new year.
Attorneys will also be watching to see if the U.S. Supreme Court decides to end litigation over an osteoporosis drug, and will track a Fifth Circuit opinion on the fate of a multimillion-dollar verdict in hip-implant litigation.
Here’s Law360’s rundown of product liability cases to watch in 2018.
In re: National Prescription Opiate Litigation
Attorneys will be closely watching the multidistrict litigation recently formed for the deluge of lawsuits filed...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!